A phase I trial for [[prostate cancer]] reported in 2009.<ref>{{cite journal | pmid = 18676760 | year = 2008 | last1 = Patel | first1 = H | last2 = Mick | first2 = R | last3 = Finlay | first3 = J | last4 = Zhu | first4 = TC | last5 = Rickter | first5 = E | last6 = Cengel | first6 = KA | last7 = Malkowicz | first7 = SB | last8 = Hahn | first8 = SM | last9 = Busch | first9 = TM | title = Motexafin lutetium-photodynamic therapy of prostate cancer: Short and long term effects on PSA | volume = 14 | issue = 15 | pages = 4869â€“76 | doi = 10.1158/1078-0432.CCR-08-0317 | pmc = 2680073 | journal = Clinical Cancer Research  }}</ref>
